1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Postoperative Pain Management Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Market Background
4.1. Market Dynamics
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Trends
4.2. Regulatory Scenario
5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2006 – 2021
5.2. Global Healthcare Market Outlook
6. Key Inclusions
6.1. Key Distributors List
7. North America Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
7.1. Introduction
7.2. Historical Market Size (US$ Mn) Analysis By Country, 2013–2017
7.2.1. U.S.
7.2.2. Canada
7.3. Market Size (US$ Mn) Forecast By Coun
7.4. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
7.4.1. Opioids
7.4.2. NSAIDS
7.4.3. Local Anaesthetics
7.4.4. Acetaminophen
7.5. Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
7.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
7.6.1. Injectable
7.6.2. Oral
7.6.3. Topical
7.6.4. Transdermal
7.6.5. Others
7.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
7.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
7.8.1. Hospital Pharmacies
7.8.2. Retail Pharmacies
7.8.3. Drug Store
7.8.4. Clinics
7.8.5. Others
7.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
7.10.Market Attractiveness Analysis
7.10.1. By Country
7.10.2. By Drug Class
7.10.3. By Route of Administration
7.10.4. By Distribution Channel
7.11.Key Market Participants – Intensity Mapping
7.12.Drivers and Restraints – Impact Analysis
8. Latin America Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
8.1. Introduction
8.2. Historical Market Size (US$ Mn) Trends Analysis By Country, 2012–2016
8.2.1. Brazil
8.2.2. Mexico
8.2.3. Rest of Latin America
8.3. Market Size (US$ Mn) Forecast By Country, 2018–2026
8.4. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
8.4.1. Opioids
8.4.2. NSAIDS
8.4.3. Local Anaesthetics
8.4.4. Acetaminophen
8.5. Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
8.6. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
8.6.1. Injectables
8.6.2. Oral
8.6.3. Topical
8.6.4. Transdermal
8.6.5. Others
8.7. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
8.8. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
8.8.1. Hospital Pharmacies
8.8.2. Retail Pharmacies
8.8.3. Drug Store
8.8.4. Clinics
8.8.5. Others
8.9. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
8.10.Market Attractiveness Analysis
8.10.1. By Country
8.10.2. By Drug Class
8.10.3. By Route of Administration
8.10.4. By Distribution Channel
8.11.Key Market Participants – Intensity Mapping
8.12.Drivers and Restraints – Impact Analysis
9. Europe Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
9.1. Introduction
9.2. Regional Market Trends
9.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
9.3.1. U.K.
9.3.2. Germany
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Rest of Europe
9.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
9.5. Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
9.5.1. Opioids
9.5.2. NSAIDS
9.5.3. Local Anaesthetics
9.5.4. Acetaminophen
9.6. Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
9.7. Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
9.7.1. Injectables
9.7.2. Oral
9.7.3. Topical
9.7.4. Transdermal
9.7.5. Others
9.8. Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
9.9. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
9.9.1. Hospital Pharmacies
9.9.2. Retail Pharmacies
9.9.3. Drug Store
9.9.4. Clinics
9.9.5. Others
9.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
9.11.Market Attractiveness Analysis
9.11.1. By Country
9.11.2. By Drug Class
9.11.3. By Route of Administration
9.11.4. By Distribution Channel
9.12.Key Market Participants – Intensity Mapping
9.13.Drivers and Restraints – Impact Analysis
10. Asia Pacific Excluding China Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
10.1.Introduction
10.2.Regional Market Trends
10.3.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
10.3.1. Japan
10.3.2. India
10.3.3. Australia and New Zealand
10.3.4. ASEAN
10.3.5. Rest of Asia Pacific
10.4.Market Size (US$ Mn) Forecast By Country, 2018–2026
10.5.Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
10.5.1. Opioids
10.5.2. NSAIDS
10.5.3. Local Anaesthetics
10.5.4. Acetaminophen
10.6.Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
10.7.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
10.7.1. Injectables
10.7.2. Oral
10.7.3. Topical
10.7.4. Transdermal
10.7.5. Others
10.8.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
10.9.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
10.9.1. Hospital Pharmacies
10.9.2. Retail Pharmacies
10.9.3. Drug Store
10.9.4. Clinics
10.9.5. Others
10.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
10.11.Market Attractiveness Analysis
10.11.1. By Country
10.11.2. By Drug Class
10.11.3. By Route of Administration
10.11.4. By Distribution Channel
10.12. Key Market Participants – Intensity Mapping
10.13. Drivers and Restraints – Impact Analysis
11. China Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
11.1.Introduction
11.2.Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
11.2.1. Opioids
11.2.2. NSAIDS
11.2.3. Local Anaesthetics
11.2.4. Acetaminophen
11.3.Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
11.4.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
11.4.1. Injectables
11.4.2. Oral
11.4.3. Topical
11.4.4. Transdermal
11.4.5. Others
11.5.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
11.6.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
11.6.1. Hospital Pharmacies
11.6.2. Retail Pharmacies
11.6.3. Drug Store
11.6.4. Clinics
11.6.5. Others
11.7.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
11.8.Market Attractiveness Analysis
11.8.1. By Drug Class
11.8.2. By Route of Administration
11.8.3. By Distribution Channel
11.9.Key Market Participants – Intensity Mapping
11.10. Drivers and Restraints – Impact Analysis
12. Middle East & Africa Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
12.1.Introduction
12.2.Regional Market Trends
12.3.Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
12.3.1. South Africa
12.3.2. GCC Countries
12.3.3. Rest of MEA
12.4.Market Size (US$ Mn) Forecast By Country, 2018–2026
12.5.Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
12.5.1. Opioids
12.5.2. NSAIDS
12.5.3. Local Anaesthetics
12.5.4. Acetaminophen
12.6.Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
12.7.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
12.7.1. Injectables
12.7.2. Oral
12.7.3. Topical
12.7.4. Transdermal
12.7.5. Others
12.8.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
12.9.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
12.9.1. Hospital Pharmacies
12.9.2. Retail Pharmacies
12.9.3. Drug Store
12.9.4. Clinics
12.9.5. Others
12.10.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
12.11.Market Attractiveness Analysis
12.11.1. By Country
12.11.2. By Drug Class
12.11.3. By Route of Administration
12.11.4. By Distribution Channel
12.12. Key Market Participants – Intensity Mapping
12.13. Drivers and Restraints – Impact Analysis
13. Forecast Factors: Relevance and Impact
14. Forecast Assumptions
15. Market Structure Analysis
15.1.Market Structure Analysis by Tier
15.2.Company Share Analysis (2017)
16. Competition Landscape
16.1.Market Structure Analysis
16.2.Competition Dashboard
16.3.Competition Benchmarking
16.4.Company Deep Dive
16.4.1. Teva Pharmaceutical Industries Ltd.
16.4.1.1. Overview
16.4.1.2. Product and Application Portfolio
16.4.1.3. Production Footprint
16.4.1.4. Sales Footprint
16.4.1.5. Channel Footprint
16.4.1.6. Strategy
16.4.1.6.1. Marketing Strategy
16.4.1.6.2. Product Strategy
16.4.1.6.3. Channel Strategy
16.4.2. Novartis AG
16.4.2.1. Overview
16.4.2.2. Product and Application Portfolio
16.4.2.3. Production Footprint
16.4.2.4. Sales Footprint
16.4.2.5. Channel Footprint
16.4.2.6. Strategy
16.4.2.6.1. Marketing Strategy
16.4.2.6.2. Product Strategy
16.4.2.6.3. Channel Strategy
16.4.3. Allergan plc
16.4.3.1. Overview
16.4.3.2. Product and Application Portfolio
16.4.3.3. Production Footprint
16.4.3.4. Sales Footprint
16.4.3.5. Channel Footprint
16.4.3.6. Strategy
16.4.3.6.1. Marketing Strategy
16.4.3.6.2. Product Strategy
16.4.3.6.3. Channel Strategy
16.4.4. Mylan N.V.
16.4.4.1. Overview
16.4.4.2. Product and Application Portfolio
16.4.4.3. Production Footprint
16.4.4.4. Sales Footprint
16.4.4.5. Channel Footprint
16.4.4.6. Strategy
16.4.4.6.1. Marketing Strategy
16.4.4.6.2. Product Strategy
16.4.4.6.3. Channel Strategy
16.4.5. Pfizer Inc.
16.4.5.1. Overview
16.4.5.2. Product and Application Portfolio
16.4.5.3. Production Footprint
16.4.5.4. Sales Footprint
16.4.5.5. Channel Footprint
16.4.5.6. Strategy
16.4.5.6.1. Marketing Strategy
16.4.5.6.2. Product Strategy
16.4.5.6.3. Channel Strategy
16.4.6. Purdue Pharma L.P
16.4.6.1. Overview
16.4.6.2. Product and Application Portfolio
16.4.6.3. Production Footprint
16.4.6.4. Sales Footprint
16.4.6.5. Channel Footprint
16.4.6.6. Strategy
16.4.6.6.1. Marketing Strategy
16.4.6.6.2. Product Strategy
16.4.6.6.3. Channel Strategy
16.4.7. Janssen Pharmaceuticals, Inc.
16.4.7.1. Overview
16.4.7.2. Product and Application Portfolio
16.4.7.3. Production Footprint
16.4.7.4. Sales Footprint
16.4.7.5. Channel Footprint
16.4.7.6. Strategy
16.4.7.6.1. Marketing Strategy
16.4.7.6.2. Product Strategy
16.4.7.6.3. Channel Strategy
16.4.8. Endo International plc
16.4.8.1. Overview
16.4.8.2. Product and Application Portfolio
16.4.8.3. Production Footprint
16.4.8.4. Sales Footprint
16.4.8.5. Channel Footprint
16.4.8.6. Strategy
16.4.8.6.1. Marketing Strategy
16.4.8.6.2. Product Strategy
16.4.8.6.3. Channel Strategy
16.4.9. Pacira Pharmaceuticals Inc.
16.4.9.1. Overview
16.4.9.2. Product and Application Portfolio
16.4.9.3. Production Footprint
16.4.9.4. Sales Footprint
16.4.9.5. Channel Footprint
16.4.9.6. Strategy
16.4.9.6.1. Marketing Strategy
16.4.9.6.2. Product Strategy
16.4.9.6.3. Channel Strategy
16.4.10. Egalet Corporation
16.4.10.1. Overview
16.4.10.2. Product and Application Portfolio
16.4.10.3. Production Footprint
16.4.10.4. Sales Footprint
16.4.10.5. Channel Footprint
16.4.10.6. Strategy
16.4.10.6.1. Marketing Strategy
16.4.10.6.2. Product Strategy
16.4.10.6.3. Channel Strategy
16.4.11. GlaxoSmithKline Plc.
16.4.11.1. Overview
16.4.11.2. Product and Application Portfolio
16.4.11.3. Production Footprint
16.4.11.4. Sales Footprint
16.4.11.5. Channel Footprint
16.4.11.6. Strategy
16.4.11.6.1. Marketing Strategy
16.4.11.6.2. Product Strategy
16.4.11.6.3. Channel Strategy
17. Global Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026, By Region
17.1.Introduction/Key Findings
17.2.Historical Market Size (US$ Mn) Analysis By Region, 2013–2017
17.3.Market Size (US$ Mn) Forecast By Region, 2018–2026
17.3.1. North America
17.3.2. Latin America
17.3.3. Europe
17.3.4. Asia Pacific excluding China
17.3.5. China
17.3.6. Middle East & Africa
17.4.Market Attractiveness Analysis By Region
18. Global Postoperative Pain Management Analysis 2013–2017 and Forecast 2018–2026, By Drug Class
18.1.Introduction/Key Findings
18.2.Historical Market Size (US$ Mn) Analysis By Drug Class, 2013–2017
18.2.1. NSAIDS
18.2.2. Opioids
18.2.3. Local Anaesthetics
18.2.4. Acetaminophen
18.3.Market Size (US$ Mn) Forecast By Drug Class, 2018–2026
18.4.Market Attractiveness Analysis By Drug Class
19. Global Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026, By Route of Administration
19.1.Historical Market Size (US$ Mn) Trend Analysis By Route of Administration, 2013–2017
19.1.1. Injectables
19.1.2. Oral
19.1.3. Topical
19.1.4. Transdermal
19.1.5. Others
19.2.Market Size (US$ Mn) Forecast By Route of Administration, 2018-2026
19.3.Market Attractiveness Analysis By Route of Administration
20. Global Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026, By Distribution Channel
20.1.Introduction/Key Findings
20.2.Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2013–2017
20.2.1. Hospital Pharmacies
20.2.2. Retail Pharmacies
20.2.3. Drug Store
20.2.4. Clinics
20.2.5. Others
20.3.Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
20.4.Market Attractiveness Analysis By Distribution Channel
21. Global Postoperative Pain Management Market Analysis 2013–2017 and Forecast 2018–2026
21.1.Market Value Projections
21.2.Y-o-Y Growth Analysis
21.3.Absolute $ Opportunity
22. Research Methodology
List of Tables
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018–2026, By Country
Table 04 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018–2026, By Drug Class
Table 05 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018–2026, By Route of Administration
Table 06 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018–2026, By Distribution Channel
Table 07 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 08 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 09 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
Table 10 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
Table 11 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 12 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 13 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
Table 14 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
Table 15 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 16 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 17 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
Table 18 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
Table 19 : China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 20 : China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
Table 21 : China Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
Table 22 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 23 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Class
Table 24 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Route of Administration
Table 25 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018-2026, By Distribution Channel
Table 26 : Global Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018–2026, By Region
Table 27 : Global Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018–2026, By Drug Class
Table 28 : Global Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018–2026, By Route of Administration
Table 29 : Global Prescription Postoperative Pain Management Market Size (US$ Mn) Analysis 2013-2017 & Forecast 2018–2026, By Distribution Channel
List of Figures
Figure 01 : Global Postoperative Pain Management Market value (US$ Mn) Forecast, 2018 – 2026
Figure 02 : Global Postoperative Pain Management Market Share, By Drug Class (2018)
Figure 03 : Global Postoperative Pain Management Market Share, By Region (2018)
Figure 04: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 05 : North America Postoperative Pain Management Market Share, By Drug Class (2018 E)
Figure 06 : North America Postoperative Pain Management Market Share, By Route of Administration (2018 E)
Figure 07 : North America Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
Figure 08 : North America Postoperative Pain Management Market Share, By Country (2018 E)
Figure 09 : North America Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 10 : North America Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 11 : U.S. Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 12 : U.S. Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 13 : Canada Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 14 : Canada Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 15 : North America Postoperative Pain Management Market Attractiveness Analysis, By Country
Figure 16 : North America Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
Figure 17: North America Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration
Figure 18 : North America Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
Figure 19 : Latin America Postoperative Pain Management Market Share, By Drug Class (2018 E)
Figure 20 : Latin America Postoperative Pain Management Market Share, By Route of Administration (2018 E)
Figure 21 : Latin America Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
Figure 22 : Latin America Postoperative Pain Management Market Share, By Country (2018 E)
Figure 23 : Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 24 : Latin America Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 25 : Brazil Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 26 : Brazil Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 27 : Mexico Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 28 : Mexico Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 29 : Rest of Latin America Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 30 : Rest of Latin America Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 31 : Latin America Postoperative Pain Management Market Attractiveness Analysis, , By Country
Figure 32 : Latin America Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
Figure 33 : Latin America Postoperative Pain Management Market Attractiveness Analysis, , By Route of Administration
Figure 34 : Latin America Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
Figure 35 : Europe Postoperative Pain Management Market Share, By Drug Class (2018 E)
Figure 36 : Europe Postoperative Pain Management Market Share, By Route of Administration (2018 E)
Figure 37 : Europe Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
Figure 38 : Europe Postoperative Pain Management Market Share, By Country (2018 E)
Figure 39 : Europe Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 40 : Europe Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 41 : U.K. Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 42 : U.K. Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 43 : Germany Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 44 : Germany Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 45: France Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 46 :France Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 47 : Italy Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 48 :Italy Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 49 : Spain Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 50 : Spain Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 51 : Russia Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 52 : Russia Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 53 : Rest of Europe Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 54 : Rest of Europe Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 55 : Europe Postoperative Pain Management Market Attractiveness Analysis, , By Country
Figure 56 : Europe Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
Figure 57 : Europe Postoperative Pain Management Market Attractiveness Analysis, , By Route of Administration
Figure 58 : Europe Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
Figure 59 : Asia-Pacific Excluding China Postoperative Pain Management Market Share, By Drug Class (2018 E)
Figure 60 : Asia-Pacific Excluding China Postoperative Pain Management Market Share, By Route of Administration (2018 E)
Figure 61 : Asia-Pacific Excluding China Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
Figure 62 : Asia-Pacific Excluding China Postoperative Pain Management Market Share, By Country (2018 E)
Figure 63 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 64 : Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 65 : Japan Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 66 : Japan Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 67 : India Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 68 : India Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 69 : Australia and New Zealand Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 70 : Australia and New Zealand Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 71 : ASEAN Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 72 : ASEAN Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 73 : Rest of Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 74 : Rest of Asia-Pacific Excluding China Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 75 : Asia-Pacific Excluding China Postoperative Pain Management Market Attractiveness Analysis, , By Country
Figure 76 : Asia-Pacific Excluding China Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
Figure 77 : Asia-Pacific Excluding China Postoperative Pain Management Market Attractiveness Analysis, , By Route of Administration
Figure 78 : Asia-Pacific Excluding China Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
Figure 79 : China Postoperative Pain Management Market Share, By Drug Class (2018 E)
Figure 80 : China Postoperative Pain Management Market Share, By Route of Administration (2018 E)
Figure 81 : China Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
Figure 82 : China Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 83 : China Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 84 : China Postoperative Pain Management Market Attractiveness Analysis, , By Drug Class
Figure 85 : China Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration
Figure 86 : China Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
Figure 87 : Middle East & Africa Postoperative Pain Management Market Share, By Drug Class (2018 E)
Figure 88 : Middle East & Africa Postoperative Pain Management Market Share, By Route of Administration (2018 E)
Figure 89 : Middle East & Africa Postoperative Pain Management Market Share, By Distribution Channel (2018 E)
Figure 90 : Middle East & Africa Postoperative Pain Management Market Share, By Country (2018 E)
Figure 91 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 92 : Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 93 : South Africa Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 94 : South Africa Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 95 : GCC Countries Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 96 : GCC Countries Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 97 : Rest of Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) Analysis, 2013–2017
Figure 98 : Rest of Middle East & Africa Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 99 : Middle East & Africa Postoperative Pain Management Market Attractiveness Analysis, , By Country
Figure 100 : Middle East & Africa Postoperative Pain Management Market Attractiveness Analysis, By Drug Class
Figure 101 : Middle East & Africa Postoperative Pain Management Market Attractiveness Analysis, , By Route of Administration
Figure 102 : Middle East & Africa Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel
Figure 103 : Global Prescription Analgesics Market Value (US$ Mn), By Region, 2018 & 2026
Figure 104 : Global Postoperative Pain Management Market Attractiveness Analysis, By Region (2018 - 2026)
Figure 105 : Global Postoperative Pain Management Market Value (US$ Mn), By Drug Class, 2018 & 2026
Figure 106 : Global Postoperative Pain Management Market Attractiveness Analysis, By Drug Class (2018 - 2026)
Figure 107 :Global Prescription Analgesics Market Value (US$ Mn), By Route of Administration, 2018 & 2026
Figure 108 : Global Postoperative Pain Management Market Attractiveness Analysis, By Route of Administration (2018 - 2026)
Figure 109 : Global Postoperative Pain Management Market Value (US$ Mn), By Distribution Channel, 2018 & 2026
Figure 110 : Global Postoperative Pain Management Market Attractiveness Analysis, By Distribution Channel (2018 - 2026)
Figure 111 : Global Postoperative Pain Management Historical Market Size and Y-o-Y, 2013- 2017.
Figure 112 : Global Postoperative Pain Management Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2026.
Figure 113 : Global Postoperative Pain Management Market Absolute $ Opportunity, 2017–2026,